LISSONI, ANDREA ALBERTO
LISSONI, ANDREA ALBERTO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Response to chemotherapy and Clinical Outcome of Patients with recurrent epithelial ovarian cancer after PARP inhibitor maintenance treatment: a Multicenter retrospective italina Study
2022 Gadducci, A; Cosio, S; Landoni, F; Lissoni, A; Zola, P; Elena Laudani, M; Ardizzoia, A; Gambino and Enrico Sartori, A
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience
2022 Adorni, M; Bazzurini, L; Lissoni, A; Vecchione, F; Negri, S; Grassi, T; Buda, A; Landoni, F
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers
2021 Ceppi, L; Grassi, T; Galli, F; Buda, A; Aletti, G; Lissoni, A; Adorni, M; Garbi, A; Colombo, N; Bonazzi, C; Landoni, F; Fruscio, R
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response
2021 DI MARTINO, G; Lissoni, A; Ferrari, D; DI MEO, M; Cosio, S; Gadducci, A; Landoni, F
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas
2021 Conconi, D; Redaelli, S; Lissoni, A; Cilibrasi, C; Perego, P; Gautiero, E; Sala, E; Paderno, M; Dalpra, L; Landoni, F; Lavitrano, M; Roversi, G; Bentivegna, A
Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial
2021 Post, C; de Boer, S; Powell, M; Mileshkin, L; Katsaros, D; Bessette, P; Haie-Meder, C; Ottevanger, N; Ledermann, J; Khaw, P; D'Amico, R; Fyles, A; Baron, M; Kitchener, H; Nijman, H; Lutgens, L; Brooks, S; Jürgenliemk-Schulz, I; Feeney, A; Goss, G; Fossati, R; Ghatage, P; Leary, A; Do, V; Lissoni, A; Mccormack, M; Nout, R; Verhoeven-Adema, K; Smit, V; Putter, H; Creutzberg, C
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study
2020 Gadducci, A; Cosio, S; Lissoni, A; Zizioli, V; Adorni, M; Ferrero, A; Landoni, F; Sartori, E
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel
2020 Lorusso, D; Bologna, A; Cecere, S; De Matteis, E; Scandurra, G; Zamagni, C; Arcangeli, V; Artioli, F; Bella, M; Blanco, G; Cardalesi, C; Casartelli, C; De Vivo, R; Di Napoli, M; Gisone, E; Lauria, R; Lissoni, A; Loizzi, V; Maccaroni, E; Mangili, G; Marchetti, C; Martella, F; Naglieri, E; Parolin, V; Ricciardi, G; Ronzino, G; Salutari, V; Scarfone, G; Secondino, S; Spagnoletti, I; Tasca, G; Tognon, G; Guarneri, V
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study
2019 Gadducci, A; Giuliani, D; Cosio, S; Lissoni, A; Ferrero, A; Landoni, F
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms
2019 Ceppi, L; Galli, F; Lamanna, M; Magni, S; Dell'Orto, F; Verri, D; Delle Marchette, M; Lissoni, A; Sina, F; Giuliani, D; Grassi, T; Landoni, F; Bonazzi, C; Fruscio, R
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery
2019 DELLE MARCHETTE, M; Ceppi, L; Andreano, A; Bonazzi, C; Buda, A; Grassi, T; Giuliani, D; Sina, F; Lamanna, M; Bianchi, T; Lissoni, A; Landoni, F; Valsecchi, M; Fruscio, R
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
2019 de Boer, S; Powell, M; Mileshkin, L; Katsaros, D; Bessette, P; Haie-Meder, C; Ottevanger, P; Ledermann, J; Khaw, P; D'Amico, R; Fyles, A; Baron, M; Jurgenliemk-Schulz, I; Kitchener, H; Nijman, H; Wilson, G; Brooks, S; Gribaudo, S; Provencher, D; Hanzen, C; Kruitwagen, R; Smit, V; Singh, N; Do, V; Lissoni, A; Nout, R; Feeney, A; Verhoeven-Adema, K; Putter, H; Creutzberg, C; Mccormack, M; Whitmarsh, K; Allerton, R; Gregory, D; Symonds, P; Hoskin, P; Adusumalli, M; Anand, A; Wade, R; Stewart, A; Taylor, W; Lutgens, L; Hollema, H; Pras, E; Snyers, A; Westerveld, G; Jobsen, J; Slot, A; Mens, J; Stam, T; Van Triest, B; Van der Steen-Banasik, E; De Winter, K; Quinn, M; Kolodziej, I; Pyman, J; Johnson, C; Capp, A; Fossati, R; Colombo, A; Carinelli, S; Ferrero, A; Artioli, G; Davidson, C; Mclachlin, C; Ghatage, P; Rittenberg, P; Souhami, L; Thomas, G; Duvillard, P; Berton-Rigaud, D; Tubiana-Mathieu, N
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer
2019 Colombo, N; Zaccarelli, E; Baldoni, A; Frezzini, S; Scambia, G; Palluzzi, E; Tognon, G; Lissoni, A; Rubino, D; Ferrero, A; Farina, G; Negri, E; Pesenti Gritti, A; Galli, F; Biagioli, E; Rulli, E; Poli, D; Gerardi, C; Torri, V; Fossati, R; D'Incalci, M
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
2018 de Boer, S; Powell, M; Mileshkin, L; Katsaros, D; Bessette, P; Haie-Meder, C; Ottevanger, P; Ledermann, J; Khaw, P; Colombo, A; Fyles, A; Baron, M; Jurgenliemk-Schulz, I; Kitchener, H; Nijman, H; Wilson, G; Brooks, S; Carinelli, S; Provencher, D; Hanzen, C; Lutgens, L; Smit, V; Singh, N; Do, V; D'Amico, R; Nout, R; Feeney, A; Verhoeven-Adema, K; Putter, H; Creutzberg, C; Mccormack, M; Whitmarsh, K; Allerton, R; Gregory, D; Symonds, P; Hoskin, P; Adusumalli, M; Anand, A; Wade, R; Stewart, A; Taylor, W; Kruitwagen, R; Hollema, H; Pras, E; Snyers, A; Stalpers, L; Jobsen, J; Slot, A; Mens, J; Stam, T; Van Triest, B; Van der Steen - Banasik, E; De Winter, K; Quinn, M; Kolodziej, I; Pyman, J; Johnson, C; Capp, A; Fossati, R; Gribaudo, S; Lissoni, A; Ferrero, A; Artioli, G; Davidson, C; Mclachlin, C; Ghatage, P; Rittenberg, P; Souhami, L; Thomas, G; Duvillard, P; Berton-Rigaud, D; Tubiana-Mathieu, N
Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential
2017 Conconi, D; Chiappa, V; Perego, P; Redaelli, S; Bovo, G; Lavitrano, M; Milani, R; Dalpra', L; Lissoni, A
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach
2016 Buda, A; Papadia, A; Zapardiel, I; Vizza, E; Ghezzi, F; DE PONTI, E; Lissoni, A; Imboden, S; Diestro, M; Verri, D; Gasparri, M; Bussi, B; DI MARTINO, G; de la Noval, B; Mueller, M; Crivellaro, C
Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection
2016 Buda, A; Lissoni, A; Milani, R
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer
2015 Signorelli, M; Lissoni, A; DE PONTI, E; Grassi, T; Ponti, S; Fruscio, R
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival
2015 Buda, A; Lissoni, A; Floriani, I; Biagioli, E; Gerardi, C; Bonazzi, C; Chiari, S; Locatelli, L; DELL' ANNA, T; Signorelli, M; Mangioni, C; Milani, R
Tumor volume as risk factor for nodal diffusion in endometrial cancer
2014 Chiappa, V; Lorusso, D; Lissoni, A; Fruscio, R; Raspagliesi, F